Leadless Versus Transvenous Single‐Chamber Ventricular Pacemakers: Real‐World Evidence From Aveir VR Coverage With Evidence Development Study

Background Aveir VR, a helix‐fixation leadless pacemaker (LP), was US Food and Drug Administration (FDA)‐approved in 2022. The performance of this novel LP has not been evaluated against transvenous single chamber ventricular pacemakers (TV‐VVI) in a real‐world setting. This observational coverage w...

詳細記述

書誌詳細

主要な著者:	James E. Ip, Peter A. Brady, Anne M. Kroman, Blandine Mondésert, Leonard Ganz, Jennifer M. Joseph, Deepti Bettampadi, Yajing Hu, Yelena Nabutovsky, Rahul N. Doshi
フォーマット:	Artigo
言語:	Inglês
出版事項:	Wiley 2025-11-01
シリーズ:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
主題:	Aveir leadless pacemakers outcomes reinterventions safety transvenous pacemakers
オンライン･アクセス:	https://www.ahajournals.org/doi/10.1161/JAHA.125.042471
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!